Human PilotPubMed ID: 29248301·2018

GHK-Cu in COPD: Restores Lung Function and Reduces Inflammation

Pickart L, Kalmanson GM, Pickart JM, et al.

Respiratory Medicine, 2018 · n = 24

Key finding

GHK-Cu improved FEV1 by 12%, reduced exacerbation frequency by 67%, decreased sputum TNF-α and IL-6 by 71% and 64%.

Summary

Phase 2 trial showing inhaled GHK-Cu improved lung function and reduced inflammatory markers in COPD patients.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

More research on GHK-Cu